Mark L. Welton

6.1k total citations · 1 hit paper
66 papers, 3.7k citations indexed

About

Mark L. Welton is a scholar working on Surgery, Oncology and Epidemiology. According to data from OpenAlex, Mark L. Welton has authored 66 papers receiving a total of 3.7k indexed citations (citations by other indexed papers that have themselves been cited), including 43 papers in Surgery, 25 papers in Oncology and 23 papers in Epidemiology. Recurrent topics in Mark L. Welton's work include Colorectal and Anal Carcinomas (26 papers), Cervical Cancer and HPV Research (20 papers) and Colorectal Cancer Surgical Treatments (12 papers). Mark L. Welton is often cited by papers focused on Colorectal and Anal Carcinomas (26 papers), Cervical Cancer and HPV Research (20 papers) and Colorectal Cancer Surgical Treatments (12 papers). Mark L. Welton collaborates with scholars based in United States, Australia and India. Mark L. Welton's co-authors include Joel M. Palefsky, J. Michael Berry, Andrew Shelton, Daniel J. Sargent, Carolyn C. Compton, Stanley R. Hamilton, Donald E. Henson, L P Fielding, Christopher G. Willett and R. V. P. Hutter and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and Gastroenterology.

In The Last Decade

Mark L. Welton

66 papers receiving 3.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Prognostic Factors in Colorectal Cancer

2000 993 citations Mark L. Welton et al. profile →

Peers

Countries citing papers authored by Mark L. Welton

Since Specialization

Citations

This map shows the geographic impact of Mark L. Welton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark L. Welton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark L. Welton more than expected).

Fields of papers citing papers by Mark L. Welton

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark L. Welton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark L. Welton. The network helps show where Mark L. Welton may publish in the future.

Co-authorship network of co-authors of Mark L. Welton

This figure shows the co-authorship network connecting the top 25 collaborators of Mark L. Welton. A scholar is included among the top collaborators of Mark L. Welton based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark L. Welton. Mark L. Welton is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	M Health Fairview: An aligned academic health system 2022 ·Surgery ·Mark L. Welton, Laura Reed, (unknown)	3
2	Transforming a Long-Term Acute Care Hospital into a COVID-19–Designated Hospital 2020 ·Surgical Infections ·(unknown), Gregory J. Beilman, (unknown), Mark L. Welton, Christopher J. Tignanelli, Andrew Olson, Jeffrey G. Chipman	8
3	The Efficacy of a Novel Surgical Device in Preventing Intraoperative Wound Contamination in an In Vivo Porcine Model 2017 ·Journal of Laparoendoscopic & Advanced Surgical Techniques ·Insoo Suh, (unknown), Jonathan Coe, (unknown), Donald E. Fry, Mark L. Welton	3
4	A Multidisciplinary Initiative to Increase Inpatient Discharges Before Noon 2016 ·JONA The Journal of Nursing Administration ·(unknown), Ann Weinacker, (unknown), (unknown), (unknown), (unknown), Neera Ahuja, David Pickham, James Hereford, Mark L. Welton	23
5	Equivocal Effect of Intraoperative Fluorescence Angiography on Colorectal Anastomotic Leaks 2015 ·Diseases of the Colon & Rectum ·Cindy Kin, (unknown), (unknown), Mark L. Welton	103
6	Predictors of Postoperative Urinary Retention After Colorectal Surgery 2013 ·Diseases of the Colon & Rectum ·Cindy Kin, Kim F. Rhoads, (unknown), Andrew Shelton, Mark L. Welton	50
7	p16 Is Superior to ProEx C in Identifying High-grade Squamous Intraepithelial Lesions (HSIL) of the Anal Canal 2013 ·The American Journal of Surgical Pathology ·(unknown), Benjamin A. Pinsky, Andrew H. Beck, Christina S. Kong, Mark L. Welton, Teri A. Longacre	18
8	Clinicopathologic and molecular features of sporadic early-onset colorectal adenocarcinoma: an adenocarcinoma with frequent signet ring cell differentiation, rectal and sigmoid involvement, and adverse morphologic features 2012 ·Modern Pathology ·Daniel T. Chang, Rish K. Pai, Lisa Rybicki, Michael DiMaio, Maneesha Limaye, Priya Jayachandran, Albert C. Koong, P. Kunz, George A. Fisher, James M. Ford, Mark L. Welton, Andrew Shelton, Lisa Ma, Daniel A. Arber, Reetesh K. Pai	248
9	Management of Anal Squamous Intraepithelial Lesions 2009 ·Clinics in Colon and Rectal Surgery ·Carlos E. Pineda, Mark L. Welton	20
10	High Resolution Anoscopy in the Planned Staged Treatment of Anal Squamous Intraepithelial Lesions in HIV-Negative Patients 2007 ·Journal of Gastrointestinal Surgery ·Carlos E. Pineda, J. Michael Berry, Naomi Jay, Joel M. Palefsky, Mark L. Welton	29
11	Role of Human Papillomavirus in Squamous Cell Metaplasia-Dysplasia-Carcinoma of the Rectum 2007 ·The American Journal of Surgical Pathology ·Christina S. Kong, Mark L. Welton, Teri A. Longacre	43
12	Use and Effectiveness of Tobacco Telephone Counseling and Nicotine Therapy in Maine 2005 ·American Journal of Preventive Medicine ·Scott J. Swartz, (unknown), (unknown), Mark L. Welton, Barbara J. Leonard	68
13	High Resolution Anoscopy and Targeted Treatment of High-Grade Squamous Intraepithelial Lesions 2005 ·Diseases of the Colon & Rectum ·Carlos E. Pineda, J. Michael Berry, Mark L. Welton	14
14	Role of Na+-Glucose Cotransport in Jejunal Meal-Induced Absorption 2000 ·Digestive Diseases and Sciences ·O. Joe Hines, Edward E. Whang, Anton J. Bilchik, Michael J. Zinner, Mark L. Welton, John S. Lane, David W. McFadden, Stanley W. Ashley	19
15	Angiogenesis, proliferation, and apoptosis in anal high-grade squamous intraepithelial lesions 2000 ·Diseases of the Colon & Rectum ·Virginia R. Litle, (unknown), Teresa M. Darragh, Lauren Kosinski, H. D. M. Moore, Karen Smith‐McCune, Robert S. Warren, Joel M. Palefsky, Mark L. Welton	24
16	General practitioners' use of aspirin in the secondary prevention of vascular events: knowledge, attitudes, and current practice. 1999 ·British Journal of General Practice ·Mark L. Welton, Peter Croft, (unknown)	9
17	Surgical treatment of pancreatic cancer 1991 ·International Journal of Pancreatology ·Edward H. Livingston, Mark L. Welton, (unknown)	67
18	Vasoactive intestinal polypeptide receptor binding sites in the human gastrointestinal tract: Localization by autoradiography 1989 ·Neuroscience ·Robert P. Zimmerman, (unknown), Christopher R. Mantyh, Steven R. Vigna, Mark L. Welton, Edward Passaro, Patrick W. Mantyh	30
19	Receptors for sensory neuropeptides in human inflammatory diseases: Implications for the effector role of sensory neurons 1989 ·Peptides ·Patrick W. Mantyh, (unknown), Christian G. Boehmer, Mark L. Welton, Edward Passaro, J.E. Maggio, Steven R. Vigna	112
20	Receptors 1988 ·The American Journal of Surgery ·Mark L. Welton, Edward Passaro	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact